KNSA vs TXN · P/E 53, rev $677.6M vs P/E 52, rev $10.29B
Kiniksa Pharmaceuticals Ltd (KNSA) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Latest reported TXN revenue for 2026-06-30 was $10.29B. Net income was $3.52B. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
KNSA currently screens at market cap $3.73B and trailing P/E 53.2. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the KNSA and TXN stock pages for the full models.
Not investment advice.